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Mineralocorticoid and glucocorticoid receptors (MRs and GRs) constitute a functionally important
dual receptor system detecting and transmitting circulating corticosteroid signals. High expression
ofMRs andGRs occurs in the same cells in the limbic system, the primary site of glucocorticoid action
on cognition, behavior, andmood; however, modes of interaction between the receptors are poorly
characterized. We used chromatin immunoprecipitation with nucleotide resolution using exo-
nuclease digestion, unique barcode, and single ligation (ChIP-nexus) for high-resolution genome-
wide characterization of MR and GR DNA binding profiles in neuroblastoma cells and demonstrate
recruitment to highly similar DNA binding sites. ExpressedMR or GR showed differential regulation
of endogenous gene targets, including Syt2 and Ddc, whereas coexpression produced augmented
transcriptional responses even when MRs were unable to bind DNA (MR-XDBD). ChIP confirmed
thatMR-XDBD could be tethered to chromatin by GR. Our data demonstrate thatMR can interact at
individual genomic DNA sites in multiple modes and suggest a role for MR in increasing the
transcriptional response to glucocorticoids. (Endocrinology 160: 1044–1056, 2019)
Adrenal glucocorticoid hormones regulate a diverserange of physiological processes, including the stress
response, immune function, and metabolic regulation,
as well as adaptive behavioral and cognitive processes.
Cortisol/corticosterone (CORT) are the predominant
forms of glucocorticoid in humans and rodents, re-
spectively. In addition to acute surges of CORT released
during classical stress responses, circulating glucocorti-
coids fluctuate in basal nonstressed conditions during
each 24-hour period. High CORT levels circulate dur-
ing the active phase of the day, with significantly lower
levels in the inactive phase establishing a characteristic
circadian profile. Underlying this circadian profile is an
ultradian profile with approximately hourly pulses of
endogenous glucocorticoid detected in rat and human
peripheral blood (1, 2), dialysates of subcutaneous ex-
tracellular fluid (3), and dialysates of extracellular fluid
from discrete brain regions, including the hippocampus,
of experimental rats (4).
The effects of CORT are mediated by two highly
homologous receptors, the type I high-affinity mineral-
ocorticoid receptor (MR) and the type II low-affinity
glucocorticoid receptor (GR) (5). Glucocorticoid hor-
mones are lipophilic and so can readily pass through the
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plasma membrane of target cells to bind to MRs and
GRs, which act via genomic and rapid nongenomic
mechanisms. Genomic effects are mediated by activated
cytoplasmic receptors that translocate into the nucleus to
precisely regulate patterns of gene transcription by in-
tegrating ligand activation with other signals, including
DNA binding sequences, posttranslational modifica-
tions, and the presence of specific transcriptional regu-
latory factors (6). The biological complexity is further
increased by the different affinities of the two receptors
for the endogenous ligand CORT and the dynamic
fluctuations of CORT levels. MR has near maximal
occupancy with the very low CORT levels of the circa-
dian nadir and remains maximally activated throughout
the interpulse interval (7). In contrast, GR requires higher
CORT levels associated with stress or the circadian peak
(8) such that ultradian CORT pulses induce fluctuations
in GR activity and DNA binding (9, 10), closely tracking
the rise and fall of ligand concentration. Furthermore,
MR andGR differ in body and brain expression patterns,
with GR widely expressed throughout the brain and MR
expression reportedly more restricted. Notably MR and
GR are both highly coexpressed in limbic regions such as
the hippocampus, amygdala, and some cortical areas (11,
12). Therefore, dynamic fluctuations in available ligand
combined with differing receptor affinities and regional
expression profiles provide a system with a complex
array of potential outcomes.
GRs and MRs contain a 94% identical (13) highly
conserved DNA binding domain that includes a proxi-
mal box (P-box) domain bearing three amino acid resi-
dues that directly contact the major groove of the DNA
binding sequence and determine hormone response ele-
ment specificity. GRs associate with specific genomic
sites in multiple ways by directly binding to DNA as
monomers or dimers or indirectly by tethering to specific
genomic loci via interactions with other transcriptional
regulatory factors such as AP-1 or nuclear factor kB (6).
MRs can recognize canonical palindromic GR binding
sequences to which receptor dimers bind in head-to-head
fashion. Specific binding sites have been identified for
MRs and GRs in rat hippocampus (14), with overlapping
hippocampal binding sites reported to range from 20%
of total GR binding sites (475 out of 1925) (14) to 77%
(10 out of 13) GR binding sites tested (15), although these
studies cannot conclusively say that MR and GR binding
occurs in the same cell types.
Therefore, we used chromatin immunoprecipitation
with nucleotide resolution using exonuclease digestion,
unique barcode, and single ligation (ChIP-nexus) meth-
odology, chosen for its ability to achieve high-resolution
ChIP sequencing (ChIP-seq) data (16) and discriminate
close binding events, to compare MR and GR binding
sites in the same cell type during a CORT pulse when
bothMR andGR are maximally activated. ChIP-nexus is
one of several recently introduced improvements to
ChIP-seq methodology that incorporate the use of
l-exonuclease digestion of captured DNA fragments 50 to
30 toward the cross-linked proteins to improve resolution
of protein binding regions. On finding that GR and MR
binding regions were highly similar, we demonstrated
GR–MR tethering capable of increasing the dynamic
range of GR-mediated transcriptional responses and
revealing new insights into the modes of interaction
between GRs and MRs.
Materials and Methods
Cell culture and reagents
Authenticated Neuro 2A (N2A) mouse neuroblast cells from
the European Collection of Authenticated Cell Cultures [RRID:
CVCL_0470 (17)] were purchased (January 2015) from Sigma-
Aldrich (St. Louis, MO) and cultured up to passage 20, during
which they showed consistent characteristic neuronal mor-
phology and, upon differentiation stimulus (18), were capable
of producing neurite projections (last tested September 2018).
Cells were maintained in DMEM (Thermo Fisher Scientific,
Waltham, MA) supplemented with 7.5% (v/v) fetal bovine
serum (Gibco, Thermo Fisher Scientific), 0.3 mM cysteine-HCl,
0.4 mM L-alanine, 0.45 mM asparagine, 0.4 mM L-aspartic
acid, 0.4 mM L-proline (Sigma-Aldrich), and 0.4 mM L-
glutamate (Thermo Fisher Scientific) (18). After two washes with
Dulbecco’s PBS (Thermo Fisher Scientific) cells were seeded in
CSS media [DMEM with 7.5% (v/v) charcoal-stripped fetal
bovine serum and the other supplements listed above] at 6
million per 15-cm plate for ChIP experiments and 0.25 million
per well in six-well plates for RNA expression analysis. Cells
were transfected ;18 hours after seeding, treated with vehicle
(ethanol, final concentration 0.01%) or 100 nM CORT (Sigma-
Aldrich) 24 to 26 hours later, and, where appropriate, CORT
was washed off by replacing the media twice with CSS-
containing media.
Plasmid constructs and transient transfections
ChIP-nexus experiments were performed with pC1-EGFP-
rGR (gift from Gordon Hager, National Cancer Institute) (19)
and pC1-mCherry-rMR (subcloned from pC1-EGFP-rMR, gift
from David Pearce, University of California San Francisco).
Plasmids encoded the EGFP fused to the N-terminal of rat GR
cDNA and the mCherry protein fused to the N-terminal of rat
MR cDNA inserted into pC1 vectors (Clontech/Takara Bio,
Mountain View, CA). Five micrograms of pC1-EGFP-rGR and
5 mg of pC1-mCherry-rMRwith 20mL of jetPRIME® (Polyplus
Transfection, Illkirch-Graffenstaden, France) at a ratio of
1:2 (w/v) was used for transfection of cells in 15-cm plates.
For RNA expression analysis, untagged mouse GR cDNA in
vector pC3 (gift from Gordon Hager, National Cancer In-
stitute) and untagged mouse MR [gift of pcDNA4/TO-mMR
from Diego Alvarez de la Rosa (20) in pSF-PGK-EMCV-Puro
(Oxford Genetics, Oxford, UK)] were expressed. MISSION®
short hairpin RNA (shRNA) TRCN0000238462 (Sigma-
Aldrich) targeting the 30 untranslated region (UTR) of NR3C1
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was coexpressed to knock down endogenous GR. Cells in six-
well plates were transfected with 4 mL of jetPRIME® [ratio of
1:2 (w/v)] perwell and a total of 2mg of DNA comprising 1mg of
shRNA vector plus 0.5 mg of GR and/or 0.5 mg of MR ex-
pression vectors, with pEGFP-C1 vector added as necessary to
keep the total amount of transfected DNA constant.
For construction of the DNA binding domain mutations
(XDBD), three amino acids in the P-box region (GR amino acids
446, 447, and 450 and MR amino acids 621, 621, and 625)
were changed to tryptophans by overlapping PCR and tradi-
tional cloning methods (21). For GR, the DNA sequence
GGAAGCTGTAAAGTC was changed to TGGTGGTGTA-
AATGG, and for the MR sequence GGCAGCTGCAAAGTC
was changed to TGGTGGTGCAAATGG, which in both cases
changed amino acids Gly-Ser-Cys-Lys-Val to Trp-Trp-Cys-Lys-
Trp. For regular ChIP analysis the mCherry or EGFP was
inserted upstream of the mouse MR-XDBD/GR-XDBD/wild-
type cDNA sequences.
For construction of A640T MR mutants a single base of
mouse MR (amino acid 640) was mutated to substitute alanine
(GCT) with threonine (ACT) by overlapping PCR and tradi-
tional cloning methods. The encoded DNA binding domain D-
loop amino acid sequence of these mutants was altered from
EGQHNYLCAGRNDCIIDK to EGQHNYLCTGRNDCIIDK.
DNA sequences of the constructs were confirmed by Sanger
sequencing.
RNA extraction and reverse transcription
Total RNA was extracted using an RNeasy Mini kit (Qia-
gen, Hilden, Germany) and treated with a TURBO DNA-free
kit (Ambion/Thermo Fisher Scientific). One microgram of RNA
was used for reverse transcription using an iScript™ cDNA
synthesis kit according to the manufacturer’s instructions.
Transcript levels were analyzed by real-time PCR using SYBR
Green Fast PCR master mix (Applied Biosystems, Thermo
Fisher Scientific) with Mcm3ap as an endogenous control that
had constant expression with/without CORT treatment.
Primers were designed with the PrimerQuest tool (Integrated
DNA Technologies, Coralville, IA).
ChIP-nexus
Hormone-treated EGFP-GR– and mCherry-MR–transfected
N2A cells were fixed in 1% formaldehyde for 10 minutes and
quenched with 3 mL of 1.25M glycine for 5minutes. Cells were
washed three times with cold PBS, scraped off in PBS supple-
mented with cOmplete EDTA-free protease inhibitor cocktail
(Roche, Basel, Switzerland), and centrifuged at 200g for
5 minutes at 4°C before freezing at 280°C. Chromatin was
prepared from cell pellets by lysis in 1 mL of lysis buffer A1 (22)
with protease inhibitors, douncing in a Wheaton Dounce ho-
mogenizer, and centrifugation at 3000g for 3 minutes at 4°C,
with two further washes in A1. The final wash was in ELB
buffer (23), and pellets were diluted 1:4 before sonication of
400-mL aliquots for four cycles (30 seconds on, 30 seconds off)
in a Bioruptor plus (Diagenode, Lie`ge, Belgium). After additions
of 40 mL of Tris-buffered saline [0.5 M Tris (pH 8), 1.5 M
NaCl], 40 mL of Triton X-100 10% (v/v), and 4.8 mL of
100 mM MgCl2, the aliquots were digested with 16 U of
benzonase for 15 minutes at 25°C and the reaction was stopped
with 80 mL of 0.5M EDTA. After centrifugation for 15 minutes
at 17,000g, 4°C, the supernatant from four aliquots was col-
lected, diluted with buffer A2 (22), and preincubated with
100 mL of binding control magnetic agarose beads (ChromoTek,
Planegg, Germany) for 2 hours at 4°C, before incubation with
100 mL of RFP-Trap®-MA [ChromoTek; catalog no. rtma-20;
RRID: AB_2631363 (24)] or GFP-Trap®-MA [ChromoTek;
catalog no. gtma-20; RRID: AB_2631406 (25)] overnight at 4°C
with rotation. The ChIP combined with l-exonuclease digestion
(ChIP-exo) treatment exactly followed the Zeitlinger laboratory–
published ChIP-nexus protocol (16). Samples were prepared
with the NEBNext adaptor, NEBNext universal PCR primer,
and NEBNext multiplex oligonucleotides for Illumina (indexes 1
to 9 of primer set 1) (21) and sequenced on an Illumina NextSeq
processed using a 500 High Output Kit v2.
ChIP
Chromatin was prepared as for ChIP-nexus up to the ad-
dition of 0.5M EDTA and centrifugation. For each ChIP, 70mg
of chromatin was diluted 1:10 in ChIP dilution buffer (26),
rotated 2 hours at 4°C with 25 mL of binding control magnetic
agarose beads (Chromotek), and precleared lysate was rotated
at 4°C overnight with 25 mL of RFP/GFP-magnetic agarose
beads (Chromotek). Washing and elution of magnetic agarose
bead complexes, reversal of crosslinks, digestion with ribonu-
clease (Roche) and proteinase K (Qiagen), and phenol-
chloroform and chloroform (Sigma-Aldrich) extractions were
as previously described (26). DNA was ethanol precipitated,
washed in 70% ethanol, and resuspended in nuclease-free water
prior to PCR amplification (21).
Sequence analysis
Illumina ChIP-nexus sequencing data were quality filtered:
reads were trimmed when the average quality of four bases
was,20; reads,29 bp were dropped and reads were trimmed
to 59 bp (9-bp barcode plus 50-bp sequence). Sequencing read
alignment to the GRCm38/mm10 mouse reference genome was
performed using Bowtie 2 short reads alignment programs
[RRID: SCR_005476 (27)]. Random barcodes were registered
and PCR duplicates containing the same random barcode were
removed. Mapped data were filtered for mapping quality .20
to select uniquely aligned reads andminimize false-positives due
to reads mapping to multiple genomic locations.
MACS2-enriched binding sites were called [RRID: SCR_
013291 (28); false discovery rate,0.05, peak width of 100 bp],
with background normalization data taken from input samples
prepared from corresponding chromatin samples without im-
munoprecipitation. Binding sites were identified as within
known genes, up to 5 kb upstream/downstream or intergenic
when farther than 5 kb from a known gene. Peaks were con-
sidered to overlap when the genomic location of the MACS2
identified enriched binding sites directly overlapped by at
least 1 bp.
Motif analysis for de novo motifs was performed with
HOMER v4.7 [RRID: SCR_010881 (29)] with repeat masking.
Genomic regions 6100-bp and 6200-bp MACS2 peak sum-
mits were analyzed for de novo motifs, and close matches were
noted. Knownmotifs were also identified near theMACS2 peak
summits using known motif probability matrices.
ChIP-nexus binding sites were predicted by the pipeline
model-based analysis of ChIP-exo (MACE) v1.2 [RRID: SCR_
005520 (30)]. To evaluate the relative positioning of GR and
MR molecules genome-wide, we first identified all regions
where there was binding for both molecules. For each of these
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overlapping sites, we used the midpoint of the GR site as
a reference and tallied covered positions for both mole-
cules relative to this point. Using this procedure, we obtained
genome-wide coverage distributions for both GR and MR at
overlapping sites.
Statistical analysis
Reverse transcription (RT)/ChIP–quantitative PCR (qPCR)
analyses were performed with a minimum of three independent
biological replicates (n $ 3), and each quantitative PCR
measurement was the mean of two separate qPCR values.
RT-qPCR analyses were compared by one-way ANOVAwith a
Tukey multiple comparisons test, and data are represented as
mean 6 SEM. Statistical significance is designated as follows:
*P , 0.05; **P , 0.01; ***P , 0.001; ****P , 0.0001.
Results
ChIP-nexus identifies GR and MR binding sites in
N2A cells
ChIP-nexus (16) was used to characterize genome-
wide DNA binding sites for MR and GR in mouse
neuroblastoma N2A cells. We chose to transiently
transfect expression vectors for mCherry-MR and EGFP-
GR because N2A cells have no MR expression, as is the
case in many cell lines (31), whereas GR expression was
present but showed minimal transactivation of a reporter
gene (21). ChIP targeting the protein tags (32) mCherry
and EGFP [Fig. 1(a) and 1(b)] achieved minimal cross-
reactivity and excellent reproducibility, and it proved
difficult to identify antibodies to the endogenous proteins
suitable for ChIP when following the withdrawal of
antibodies used in previous studies (14, 15). Preliminary
testing of tagged EGFP-GR/mCherry-MR with an mouse
mammary tumor virus promoter luciferase reporter
construct (pFC31-luciferase) in N2A cells showed that
the tagged GR andMRwere functionally able to activate
reporter gene transcription following CORT induction
(21). The EGFP tag on GR and the mCherry tag on MR
did not significantly alter transactivation potential in
N2A cells, although subtle changes in response amplitude
prompted the use of untagged MR and GR in all ex-
periments when tags were not essential for ChIP. We
assume that the tags do not alter DNA binding or in-
teraction with other factors tethering the receptor to
the DNA.
For the ChIP-nexus experiments, N2A cells were
seeded in charcoal-stripped serum media before transient
transfection with both mCherry-MR and EGFP-GR.
After incubation for 24 to 26 hours, transfected cells
were treated with (i) vehicle for 20 minutes, (ii) 100 nM
CORT for 20 minutes, or (iii) 100 nM CORT for 20
minutes followed by a wash and media replacement
without CORT for a further 40 minutes of incubation,
with three replicates (n 5 3) for each condition.
Chromatin was prepared and treated according to the
published ChIP-nexus protocol (16), with sequencing
performed using lllumina NextSeq. Sequence data were
quality filtered and mapped to mouse genome mm10.
PCR duplicates containing the same random barcode at
the same locus were removed, and mapped data were
filtered on mapping quality ($20) to retain reliably
mapped reads and minimize mapping to highly repetitive
regions, thereby reducing false-positives. For MR and
GR ChIP-nexus, each treatment contained at least 8.9
million uniquely mapped reads (8.9 to 27 million), with
individual replicates containing at least 1.9 million reads
(1.9 to 12.54 million reads) (21). Sequence data are
deposited in the National Center for Biotechnology In-
formation’s Gene ExpressionOmnibus and are accessible
through accession no. GSE115417 (33). Mapped reads
were analyzed using MACS2 peak calling to identify
enriched binding sites with a false discovery rate cutoff at
0.05 (34, 35).
The number of MACS2-enriched binding sites iden-
tified for MR and GR in each condition (replicates
combined) and the number of known genes with asso-
ciated binding sites (25 to 15 kb) showed, as expected,
that the greatest MR and GR binding was found after 20
minutes of CORT (treatment ii) (Table 1). Most of these
binding sites were located within genes or within 5 kb
upstream/downstream of genes. Only 28% of MR and
27% of GR binding sites were located in intergenic re-
gions (.5 kb from a known gene) [Fig. 1(c)]. Many of
the MR/GR-targeted genes were found to have more
than one associated binding site (37% MR/32% GR)
[Fig. 1(d)].
After CORT and washout (treatment iii), the binding
of GR to chromatin was dramatically reduced to only
2.3% of the number of sites identified after CORT
(treatment ii) [Fig. 1(e)], as expected, because a lower
CORT concentration would reduce GR ligand binding
and consequently GR occupancy. The appearance and
disappearance of GR binding in vehicle, CORT, and
washout treatments validates the hormone dependency
of this dataset. A different binding pattern was seen for
MR with 33% of the number of binding sites present
even after CORT was washed out [Fig. 1(f)]. Retained
MR binding is consistent with the higher affinity thatMR
has for glucocorticoids, promptingMR to associate more
readily with DNA than does the lower-affinity GR. Most
of the MR binding sites (77%) identified after washout
(treatment iii) directly overlapped with MR binding sites
found after CORT (treatment ii), consistent with retained
MR binding at the same sites. Mapped ChIP-nexus data
for GR and MR at the well-known GR-targeted gene
Fkbp5 is shown [Fig. 1(g)] and illustrates diminished GR
binding after CORT washout (treatment iii), although
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substantial MR binding is retained after the same
treatment. MACS2 analysis of the individual replicates
treated with CORT (treatment ii) identified up to 6320
MR/7025 GR binding sites per replicate (21), with 5815
MR/1197 GR binding sites being reproducibly called in
at least two out of three repeats with a direct genomic
overlap of at least 1 bp.
To discover motifs enriched at the MR/GR binding
sites, MACS2 identified binding sites from combined
replicates (MACS2 peak summits 6100 to 200-bp,
treatment ii) were analyzed for de novo motifs using
HOMER. The most significant motif was found to be
98%/97% (MR/GR sites) similar to the canonical glu-
cocorticoid response element (GRE) and present in
Figure 1. ChIP-nexus identifies GR and MR binding sites in N2A cells. (a and b) ChIP-qPCR showing specificity of (a) GFP and (b) RFP antibodies.
N2A cells transiently transfected with EGFP-GR show the ChIP-qPCR signal detected by the GFP antibody with minimal cross-reactivity to the RFP
antibody. Transfection with mCherry-MR shows the ChIP-qPCR signal detected by the RFP antibody with minimal cross-reactivity to the GFP
antibody. EGFP-GR and mCherry-MR were cotransfected with shRNA to NR3C1-30UTR to minimize possible endogenous GR effects, treated with
100 nM CORT for 20 min, and primers were located at the Sgk1 gene. Data are represented as means relative to percentage input 6 SEM (n 5
3; one-way ANOVA with a Tukey test). (c) Graph shows the distribution of MACS2-identified GR and MR binding sites within known genes,
5 kb upstream, 5 kb downstream, and intergenic regions for each treatment group: (i) vehicle for 20 min, (ii) 100 nM CORT for 20 min, and (iii)
100 nM CORT for 20 min, washout, and further incubation for 40 min. (d) Graph shows the number of genes with single or multiple associated
binding sites for GR/MR with treatment (ii). (e and f) Area-proportional Venn diagrams show the proportions of GR and MR MACS2 binding sites
that directly overlap by at least 1 bp between treatments (i), (ii), and (iii). (g) University of California Santa Cruz Genome Browser image at the
Fkbp5 gene shows comparison of mapped MR and GR ChIP-nexus data for each treatment group. ***P , 0.001; ****P , 0.0001. Ab,
antibody; veh, vehicle.
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58%/58% of sites. Other enriched motifs closely matched
GATA transcription factors GATA3 (MR and GR) and
GATA4 (MR), components of the AP-1 transcription
factor FOS (MR) and JDP2 (MRandGR), aswell asHSF1
(GR) [Fig. 2(a)]. The distribution of transcription factor
binding sites using known motif matrices (21) around the
MACS2 peak summits showed that only the GRE motif
had a clear localization pattern that was centered, as
expected, on the peak summit [Fig. 2(b) and 2(c)]. The
enrichment of GATA3 motifs was found equally in
binding sites containing GRE motifs (47% GR/50%MR)
and sites without GRE motifs (51% GR/53% MR).
Similarly, AP-1 motifs were enriched in both GRE-
containing sites (11% GR/9.3% MR) and sites without
GRE-like motifs (12.6% GR/11.5% MR). However,
comparison of GR-only, MR-only, and GR1MR over-
lapping sites revealed slightly more enrichment of AP-1
and NF-1 known motifs in GR-only (18.5% AP-1/12.6%
NF-1) and overlapping sites (19.2%/12.6%) compared
with MR-only sites (16.3%/9.21%). Sites binding MR
only were slightly more enriched for GATA3 and Phox2a
known motifs (31.3% GATA3/10.3% Phox2a) than
GR-only sites (28.1%/7.9%) or overlapping sites
(28.7%/8.9%).
MR and GR binding sites are highly similar
Comparison of MR and GR binding sites after CORT
(treatment ii) showed a large intersection of binding sites
to which MR and GR both bind, with 66% of GR
binding sites having a direct overlap of at least 1 bp with
MR binding sites [Fig. 3(a)–3(c)] (21). To clarify how the
GR and MR binding sites relate to each other, a pub-
lished ChIP-nexus data analysis pipeline, MACE (36),
was used, which identifies the staggered ChIP-nexus
borders characteristic of receptor binding regions by
interrogating the plus and minus strand data separately.
Identified border pairs flanking regions protected from
Figure 2. De novo and known transcription factor binding motifs near MR/GR binding sites. (a) De novo motifs identified in association with GR/
MR binding sites within 100/200 bp of the MACS2 peak summits and corresponding close matches to known motifs. (b and c) Frequency of
known motifs GRE, GATA3, and AP-1 around (b) MR and (c) GR MACS2 peak summits.
Table 1. MACS2 Enrichment Peaks Identified
Treatment
MACS2 Peaks
Known Genes
(25 kb to
15 kb) With
Associated
Peaks
MR GR MR GR
(i) Vehicle 73 64 30 21
(ii) CORT 14,638 10,602 10,046 7312
(iii) CORT and wash 4885 246 3253 145
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l-exonuclease digestion precisely define the DNA
binding sites [Fig. 3(d)]. In total, 1184 MACE border
pairs were identified with GR binding and 3285 withMR
binding after CORT treatment. These highly confident
binding sites correspond to 346 genes targeted byGR and
1225 genes by MR. The sizes of the regions identified
were 10 to 60 bp for both MR and GR, with some larger
regions (80 to 100 bp) for GR (21). To compare the
predicted positions of GR and MR relative to each other
on the chromatin, we evaluated the relative positioning of
GR and MR molecules genome wide at overlapping
binding sites. We obtained coverage distributions for
both GR and MR relative to the midpoint of the GR
binding region as a reference that, given the range of
binding region sizes and the degree of overlap, covered
positions up to 155 nucleotides away from the midpoint.
The distributions were highly similar showing that GR
and MR were recruited to precisely the same DNA re-
gions [Fig. 3(e)].
Differential effects of GR and MR on
gene expression
Gene expression levels of several genes to which GR
and MR both bound in N2A ChIP-nexus were measured
by RT-qPCR. RNAwas extracted fromN2A cells treated
with 100 nM CORT for 120 minutes and transiently
transfected with expression constructs for untagged GR/
MR alone, GR and MR together, or an EGFP control.
shRNA targeting GR 30UTR (NR3C1-30UTR) was
cotransfected in these experiments to minimize potential
Figure 3. MR and GR binding sites are highly similar. (a) Area-proportional Venn diagram shows MACS2 binding sites for MR that directly
overlap with GR binding sites by at least 1 bp after 20 min of CORT (treatment ii). (b and c) University of California Santa Cruz Genome Browser
images of mapped ChIP-nexus data and MACS2 peaks for MR/GR in mCherry-MR– and EGFP-GR–transfected N2A cells after 20 min of CORT
(treatment ii) at the (b) Syt2 gene and (c) Ddc gene. (d) Diagram shows how l-exonuclease digestion of ChIP fragments defines the binding
regions. (e) Distribution of coverage for the MACE-predicted binding regions for GR and MR after CORT for 20 min (treatment ii) shows highly
similar binding locations.
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effects from endogenous GR. The inclusion of transfected
shNR3C1-30UTR was shown to be effective at reducing
endogenous GR mRNA (to 29%) and GR protein (to
33%) (21). We also measured reporter gene activation
and transcriptional effects of endogenous GR in N2A
cells, which were found to be minimal in N2A cells (21).
Changes in gene expression levels included upregulation
[Syt2 and Sgk1, Fig. 4(a) and 4(b)] and downregulation
[Dusp4 andDdc, Fig. 4(c) and 4(d)] relative to the EGFP-
transfected control. When transfected alone, MR elicited
only small changes in gene expression whereas GR
caused greater gene induction/repression. Interestingly,
when GR andMRwere cotransfected the upregulation of
Syt2 mRNA was further increased compared with both
MR and GR alone [Fig. 4(a)], and the downregulation of
Dusp4mRNA andDdc nascent RNA became significant
compared with MR alone [Fig. 4(c) and 4(d)]. These
augmented changes could possibly be due to additive
effects of GR and MR individually, or they could rep-
resent interactions between GRs and MRs giving rise to
altered activation/repression.
MR DNA binding is not required for
augmented effects
To investigate the mechanism mediating augmenta-
tion, MR and GR expression vectors were constructed
with mutated DNA binding domains (XDBD) containing
three amino acid substitutions in the DBD P-box, which
is critical for DNA binding site recognition (37). This
type of mutation has previously been demonstrated
to prevent steroid receptor interactions with DNA
(38), permitting us to interrogate whether augmentation
required direct or indirect interaction with genomic
binding sites.
Gene expression was measured using transfected wild-
type and mutant GR and MR expression vectors alone
and in combination. Augmented gene expression was
observed for Syt2 when mutant MR-XDBD was coex-
pressed with wild-type GR [Fig. 4(a)]. Similarly, the
downregulation of Dusp4 mRNA and Ddc nascent
RNA, relative to MR expression, became significant
when MR-XDBD was coexpressed with GR, as it was
when wild-type MR was coexpressed with GR. Taken
together, this demonstrates that MR did not require
DNA binding to exert an effect. In contrast, when mutant
GR-XDBD was coexpressed with MR, no significant
changes in gene expression were observed, suggesting
that GR binding is necessary for GR regulation. The
finding that augmented gene expression could be induced
even when MR was unable to bind the DNA demon-
strated that augmentation was not due to the additive
effects of MRs and GRs acting individually. Instead, the
expression changes most likely result from interactions
between GRs andMRs in a manner that is not dependent
on MR binding DNA.
MR is tethered to genomic DNA by GR
To confirm that our XDBD mutations failed to bind
N2A DNA and that the proposed MR–GR interaction
was taking place on genomic DNA, further XDBD
constructs were made with mCherry and EGFP tags
suitable for ChIP testing. Wild-type mCherry-MR inter-
acted with genomic DNA at the Syt2, Sgk1, Dusp4, and
Ddc binding sites [Fig. 5(a)–5(d)], although apparently
Figure 4. Differential effects of GR and MR on gene expression. (a–d) Graphs show (a) Syt2 mRNA, (b) Sgk1 mRNA, (c) Dusp4 mRNA, and (d)
Ddc nascent RNA changes in N2A cells with expressed wild-type MR and GR individually or combined, and MR-XDBD/GR-XDBD mutants
individually or in combination with GR/MR. RT-qPCR data from N2A cells treated with 100 nM CORT for 2 h after transient transfection for 24 h
with MR/GR/MR1GR expression plasmids and cotransfection of NR3C1-30UTR shRNA to minimize endogenous GR effects. Data are represented
as mean fold changes relative to EGFP-transfected controls 6 SEM (n $ 3). *P , 0.05; **P , 0.01; ***P , 0.001.
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nonproductively (Fig. 4), and the binding at the Sgk1 site
was very weak, which may reflect a degree of epitope
masking at this target. Mutant mCherry-MR-XDBD did
not bind to the DNA on its own but was recruited to all
four binding sites when coexpressed with wild-type GR
[Fig. 5(a)–5(d)]. This shows that mutant MR can be
tethered to genomic DNA by an interaction with GR,
because it cannot bind to the DNA on its own.
Figure 5. MR is tethered to genomic DNA by GR. (a–d) ChIP-qPCR shows mCherry-MR-XDBD binding to chromatin without/with cotransfected
wild-type GR or MR at the (a) Syt2, (b) Sgk1, (c) Dusp4, and (d) Ddc binding sites. (e–h) ChIP-qPCR shows EGFP-GR-XDBD binding to chromatin
with/without cotransfected wild-type MR or GR at the (e) Syt2, (f) Sgk1, (g) Dusp4, and (h) Ddc binding sites. N2A cells were treated with
100 nM CORT for 20 min (a–h). (i and j) ChIP-qPCR shows mCherry-MR-XDBD binding to chromatin at the (i) Syt2 and (j) Ddc binding sites with
treatments: vehicle for 20 min, 100 nM CORT for 20 min, or 100 nM CORT for 20 min, washout, and further incubation for 40 min. Data are
taken from representative ChIP experiments (n 5 3) expressed as a percentage of input. N2A cells were transiently transfected with mCherry-MR
(wild-type)/mCherry-MR-XDBD/MR and EGFP-GR/EGFP-GR-XDBD/GR or an EGFP control, with shRNA to endogenous NR3C1-30UTR. Ab, antibody;
veh, vehicle; wt, wild-type.
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Additional testing was performed with wild-type and
mutant mCherry-MR and EGFP-GR in different coex-
pressed combinations. mCherry-MR-XDBD could be
tethered to DNA binding sites by GR as well as by wild-
type MR at the Syt2, Dusp4, and Ddc sites [Fig. 5(a),
5(c), and 5(d)]. EGFP-GR-XDBD could be tethered to
DNA by wild-type GR at all sites [Fig. 5(e)–5(h)], but
only by wild-type MR at the Dusp4 and Ddc sites. As
Syt2 could load MR1MR-XDBD, GR1GR-XDBD, or
GR1MR-XDBD and Ddc could load MR1MR-XDBD,
GR1GR-XDBD,GR1MR-XDBD, andMR1GR-XDBD,
we conclude that a single binding site appears capable of
loading a variety of receptor complexes. The tethering of
DNA binding–deficient forms of MR or GR by wild-type
GR or MR has not previously been described. It is
presently unclear as to the stoichiometry of the tethered
complexes because GR and MR have typically been
reported as dimers at DNA in crystal structures, but
recent studies of GR DNA binding at a chromatinized
DNA array in live cells found predominantly tetra-
mers (19).
Because a CORT pulse followed by washout (treat-
ment iii) diminishes GR binding [Fig. 1(c) and 1(e)], we
predicted that if MR-XDBD was binding via GR,
washout of CORT should diminish the binding of MR-
XDBD observed when GR was also present. We per-
formed further ChIP experiments using both GR and
mCherry-MR(wild-type) or mCherry-MR-XDBD. Both
MR and MR-XDBD appeared at the Syt2 and Ddc
binding sites after CORT induction but only MR(wild-
type) binding was retained after CORT washout, con-
firming our prediction [Fig. 5(i) and 5(j)]. This further
supports the idea that GR is tethering MR to DNA
binding sites.
Tethering of MR-XDBD to GR could be via the
classical dimerization interface, as a heterodimer, or by a
different interface, and thus we created additional mu-
tants to investigate how MR-XDBD and GR were
interacting. Based on the rat GR A477T mutant with a
disrupted D-loop dimerization interface, we made an
equivalent Ala to Thr mutation (MR A640T) within the
D-loop of MR that has a highly homologous DBD with
identical sequence at this region.We observed augmented
transcriptional response of the Syt2 gene in the presence
of both GR and MR even when MR was mutated in the
D-loop dimerization interface (GR1MR-A640T/GR1
MR-XDBD-A640T) (Fig. 6). A similar trend was ob-
served at the Ddc gene. These results point to MR
tethering by a novel form of MR–GR interaction, rather
than heterodimerization.
Taken together, the gene expression and ChIP data
findings show a newmode of interaction forMR, namely
thatMR can be tethered by GR to the DNA in such a way
that it can function to alter gene expression levels. It has
been known that MR can bind directly to palindromic
GR binding sites, but these data show that it is also
possible for MR to bind indirectly to the same DNA sites
by GR tethering. Thus, multiple modes ofMR interaction
are possible on the same genomic sequences.
Discussion
We propose a new mode of action for MR in which
it can alter transcription when tethered to the DNA by
GR. This MR–GR interaction is consistent with previ-
ous findings such as the presence of MR and GR in
vivo on the same ChIP fragments (39) and earlier
data showing inhibition of GR activation (40) or co-
operative gene activation (41) with reporter constructs.
The latter parallels our own observations of augmented
gene activation/repression on two endogenous genes,
although we now demonstrate augmentation within the
native chromatin context, which is considerably more
restrictive to receptor access than reporter plasmid
DNA (42).
The mode of MR–GR interaction appears to be via a
novel form of MR–GR interaction, rather than hetero-
dimerization, because MR A640T D-loop mutants
were equally able to direct augmented gene expression
changes. The equivalent amino acid to A640 has been
described as a central mediator in the interaction of GR
homodimers, and this residue supports the identical in-
terface between MR and GR in the classical heterodimer
model of interaction (40, 43). MR–GR interactions via
interfaces other than the classical dimerization interface
have been reported, including interaction between the
N-terminal domain of MR with GR (44) and between
MR and the ligand binding domain of GR, which was
necessary for MR-mediated nuclear translocation of a
translocation-deficient GR variant (45).
Importantly, we show that GR–MR interactions do
occur in endogenous genomic contexts and that they
have functional consequences on gene transcription,
including increasing gene upregulation and down-
regulation. In this way, the tetheredMR–GR interactions
we identified can enhance the magnitude of the tran-
scriptional response to glucocorticoids.
We show in neuroblastoma cells that CORT-activated
MR is recruited to binding sites that frequently harbor
GRE motifs (58%). This is in contrast to a study in
kidney cells (46) where only 7.4% of MR binding sites
were found to contain GRE-like motifs, leading to the
suggestion that MRwas likely to interact with chromatin
via other transcription factors instead of directly binding
to DNA sites. As different cell types and ligands (aldo-
sterone vs CORT) were used in the two studies, the
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discrepancy may be due to cell type–specific variations
in the chromatin landscape, as previously described
(47–49), and/or ligand-specific differences in MR bind-
ing. It is also possible that overexpression of the MR
protein may have resulted in increased MR binding at
GRE-containing sites in our study. However, consistent
with our findings for a high proportion of MR binding
sites containing GRE motifs, an MR ChIP-seq study in
rat hippocampus reported a high proportion of GRE
motifs underlying MR binding loci (14).
GR DNA binding has been shown to be a highly
dynamic process (50) with rapid exchange of GR at
binding sites. In vivo GRs are ligand activated only
during ultradian peaks of glucocorticoid secretion (7) and
during the stress response. Therefore, genomic GR–MR
interactions can only occur at these times, and we expect
GR–MR augmented regulations to show pulsatile profiles
in a similar way to GR alone (51). Within such a dy-
namic responsive system, enhanced transcriptional re-
sponses through GR–MR interactions provide increased
sensitivity to CORT signaling as well as an increased
magnitude of response. However, we do not yet know
how widespread MR–GR tethering is, as we have only
assessed this at selected sites and measured the outcome
for expression of a few candidate glucocorticoid target
genes.
MR and GR are strongly coexpressed in the hippo-
campus, and decreased MR levels or MR/GR ratios are
implicated in stress and psychiatric diseases (52, 53). The
tethering of MR to GR provides a new insight into how
the signaling via these receptors could be restricted when
MR levels diminish. It is now recognized that MR and
GR coexpress in adipocytes, bone osteoblasts, monocytes
and macrophages, and in cells of the kidney collecting
duct (54). Although our present work was performed
in a neuronal cell line, similar functional MR–GR in-
teractions may additionally occur in other cell types.
Access of glucocorticoids to MR is controlled by the
balance of two related enzymes, 11b-hydroxysteroid
dehydrogenase (11b-HSD) 1 and 11b-HSD2 (55). Glu-
cocorticoid action throughMR is physiologically normal
for some cell types such as osteoblasts (56) and hippo-
campal neurons (57) where 11b-HSD1 is dominant and
active glucocorticoids are locally regenerated from in-
active metabolites. However, 11b-HSD1 dominance may
also arise as a consequence of disease state (54) in cell
types where 11b-HSD2 activity would normally domi-
nate and ensure MR selectivity to aldosterone by de-
struction of active glucocorticoids. Thus, our finding of
augmented GR-mediated responses as a consequence of
MR tethering may be mechanistically relevant beyond
the brain.
Specifically, we observed changes in the regulation
of Syt2, a synaptotagmin Ca21 sensor responsible for
exocytosis, shown to be required for ensuring fast feed-
forward inhibition at g-aminobutyric acid–ergic junc-
tions, at least in the cerebellum (58). Our results identify
Syt2 as a novel glucocorticoid-responsive gene and show
MR–GR augmentation achieves increased expression of
Syt2, and consequently tethered MR may be necessary
for ensuring efficient inhibitory tone in some neural
microcircuits.
Figure 6. Effects of MR-A640T mutation on gene expression. (a and b) Graphs show (a) Syt2 mRNA and (b) Ddc nascent RNA changes in N2A
cells with expressed wild-type GR and MR/MR-XDBD/MR-A640T/MR-XDBD-A640T individually or combined. RT-qPCR data are shown from N2A
cells treated with 100 nM CORT for 2 h after transient transfection for 24 h with MR/GR/MR1GR expression plasmids and cotransfection of
NR3C1-30UTR shRNA to minimize endogenous GR effects. Data are represented as mean fold changes relative to EGFP-transfected controls 6
SEM (n $ 3). *P , 0.05; ***P , 0.001.
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We present a novel mode of action for MR that in-
creases the magnitude and sensitivity of GR-modulated
responses, at least forDdc and Syt2. Further investigation
is warranted to assess the genome-wide impact of teth-
ered MR on gene expression changes, as this mechanism
could prove to be highly important in understanding
hypothalamic–pituitary–adrenal activity and regulation.
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